← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jan 1, 2008
Akeso Pharmaceuticals, Inc.— Founded
2020s
- Apr 23, 2025
penpulimab— Marketing Organization
Drugs by trial phase (64 distinct, 169 trials)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (20 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Coronavirus Infections
- Dermatitis
- Dermatitis, Atopic
- Esophageal Neoplasms
- Hodgkin Disease
- Hypercholesterolemia
- Hyperlipoproteinemia Type II
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Melanoma
- Nasopharyngeal Carcinoma
- Neoplasms
- Psoriasis
- Uterine Cervical Neoplasms
Marketed drugs (1)
Recent trials (50)
- NCT07264075CollaboratorPhase 3Jan 31, 2026
- NCT07263919Lead sponsorPhase 2Dec 31, 2025
- NCT07301502Lead sponsorPhase 1Dec 31, 2025
- NCT07245446Lead sponsorPhase 2Oct 29, 2025
- NCT07208773CollaboratorPhase 1/Phase 2Oct 29, 2025
- NCT07281326Lead sponsorPhase 1Oct 22, 2025
- NCT07281326OfficialPhase 1Oct 22, 2025
- NCT07158840Lead sponsorPhase 2Sep 5, 2025
- NCT07162714CollaboratorPhase 2Sep 1, 2025
- NCT07114315Lead sponsorPhase 2Aug 31, 2025
- NCT07067567Lead sponsorPhase 1Aug 7, 2025
- NCT07023315Lead sponsorPhase 3Jul 31, 2025
- NCT06959550CollaboratorPhase 2Jul 28, 2025
- NCT07052253Lead sponsorPhase 2Jul 25, 2025
- NCT06913218Lead sponsorPhase 1Jul 22, 2025
Details
- Founded
- Saint Petersburg, RU Jan 1, 2008
- Last known activity
- Jan 31, 2026